Saccharomyces boulardii and Fish oil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Saccharomyces boulardii and Fish oil. Common interactions include movement disorder among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people who take Saccharomyces boulardii and Fish oil have. It is created by eHealthMe based on reports of 24 people who take Saccharomyces boulardii and Fish oil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 18, 2023

24 people who take Saccharomyces boulardii and Fish oil together, and have interactions are studied.


What is Saccharomyces boulardii?

Saccharomyces boulardii has active ingredients of saccharomyces boulardii. eHealthMe is studying from 772 Saccharomyces boulardii users for its effectiveness, alternative drugs and more.

What is Fish oil?

Fish oil has active ingredients of fish oil. It is often used in high blood cholesterol. eHealthMe is studying from 107,630 Fish oil users for its effectiveness, alternative drugs and more.

Number of Saccharomyces boulardii and Fish oil reports submitted per year:

Saccharomyces boulardii and Fish oil drug interactions.

Common Saccharomyces Boulardii and Fish Oil drug interactions by gender *:

female:

  1. Movement disorder
  2. Multiple sclerosis relapse
  3. Muscle spasticity
  4. Musculoskeletal disorder
  5. Myocarditis
  6. Nasal congestion
  7. Nasopharyngitis
  8. Neck pain
  9. Neuropathy peripheral
  10. Ocular discomfort

male:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Head discomfort
  4. Impaired healing
  5. Infrequent bowel movements
  6. Insomnia
  7. Iron deficiency
  8. Laziness
  9. Malaise
  10. Mood altered

Common Saccharomyces Boulardii and Fish Oil drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood pressure decreased
  2. Chest pain
  3. Headache
  4. Hypoaesthesia
  5. Lethargy
  6. Migraine
  7. Myocarditis
  8. Pulmonary function test decreased
  9. Restless legs syndrome
  10. Systemic lupus erythematosus

20-29:

  1. Haematochezia
  2. Haemorrhoids

30-39:

  1. Malaise
  2. Mood altered
  3. Multiple sclerosis relapse
  4. Nasopharyngitis
  5. Night sweats
  6. Paraesthesia
  7. Poor quality sleep
  8. Psychiatric symptom
  9. Scar
  10. Tinnitus

40-49:

  1. Breast cancer
  2. Cardiac failure congestive
  3. Cataract
  4. Constipation
  5. Diabetes mellitus
  6. Dyspnoea
  7. Facial paralysis
  8. Gastrointestinal disorder
  9. Hepatic cirrhosis
  10. Hepatic encephalopathy

50-59:

  1. Fatigue
  2. Headache
  3. Hypoaesthesia
  4. Injection site haemorrhage
  5. Injection site pain
  6. Injection site rash
  7. Injection site urticaria
  8. Neck pain
  9. Paraesthesia
  10. Piloerection

60+:

  1. Dizziness
  2. Hyponatraemia
  3. Diarrhoea
  4. Faeces discoloured
  5. Gait disturbance
  6. Anxiety
  7. Crohn's disease
  8. Wheezing
  9. Balance disorder
  10. Confusional state

Common conditions people have *:

  1. Pain: 4 people, 16.67%
  2. Nausea (feeling of having an urge to vomit): 4 people, 16.67%
  3. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 4 people, 16.67%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 12.50%
  5. Local Anaesthesia: 3 people, 12.50%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.33%
  7. Insomnia (sleeplessness): 2 people, 8.33%
  8. Hypersensitivity: 2 people, 8.33%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 8.33%
  10. Blood Iron Decreased: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Saccharomyces boulardii and Fish oil?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Saccharomyces boulardii and Fish oil interactions:

Browse all drug interactions of Saccharomyces boulardii and Fish oil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Saccharomyces boulardii side effects:

Browse all side effects of Saccharomyces boulardii:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fish oil side effects:

Browse all side effects of Fish oil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Saccharomyces boulardii interactions:

Browse all interactions between Saccharomyces boulardii and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fish oil interactions:

Browse all interactions between Fish oil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on saccharomyces boulardii and fish oil (the active ingredients of Saccharomyces boulardii and Fish oil, respectively), and Saccharomyces boulardii and Fish oil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Saccharomyces boulardii and Fish oil.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: